Eosinophile Granulomatose mit Polyangiitis: Mepolizumab in aktueller Leitlinie empfohlen
Crossref DOI link: https://doi.org/10.1007/s15007-024-6373-3
Published Online: 2024-10-31
Published Print: 2024-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Facharztmagazine, Redaktion
Text and Data Mining valid from 2024-10-31
Version of Record valid from 2024-10-31
Article History
First Online: 31 October 2024